Stocks · Health care · Biological Products, (No Diagnostic Substances)

FATE THERAPEUTICS INC

FATE Clue Score25

United States Fiscal year ends December CIK 0001434316 Results filed 5 Nov 2026

Add to watchlist

What the insiders did Net buying

By person

23 insiders · 388 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Redmile Group, LLC entity

Director

$135.69M (9)

$2.34M (2)

+$133.35M

38,801,402

32.38%

$79.73M

+20.5%

J Scott Wolchko

President and CEO

—

$49.07M (80) scheduled

−$49.07M

371,248

0.3098%

$762.84K

+161.4%

Cindy Tahl

See Remarks

—

$28.74M (65) scheduled

−$28.74M

589,355

0.4919%

$1.21M

+1,001%

Amir Nashat

Director

—

$22.96M (84)

−$22.96M

11,034

0.0092%

$22.67K

−99.2%

Bahram Valamehr

President and CEO

—

$14.35M (55) scheduled

−$14.35M

591,815

0.4939%

$1.22M

+659.1%

Daniel D Shoemaker

Chief Scientific Officer

—

$6.63M (29)

−$6.63M

73,020

0.0609%

$150.04K

−29.7%

Edward J Dulac III

Chief Financial Officer

—

$2.88M (17) scheduled

−$2.88M

101,479

0.0847%

$208.52K

—

Yu-Waye Chu

Chief Medical Officer

—

$1.05M (16)

−$1.05M

140,676

0.1174%

$289.06K

+106.6%

William H Rastetter

Director

$1,000.00K (1)

—

+$1,000.00K

642,424

0.5362%

$1.32M

+218.5%

John Mendlein

Director

$698.14K (2)

$1.14M (3) scheduled

−$438.15K

311,231

0.2597%

$639.52K

+110.1%

Timothy Coughlin

Director

$150.00K (1)

$32.82K (1)

+$117.17K

9,892

0.0083%

$20.33K

—

Mark Plavsic

Chief Technical Officer

—

$109.43K (2)

−$109.43K

123,705

0.1032%

$254.19K

—

Chris Storgard

Chief Medical Officer

$100.00K (1)

—

+$100.00K

46,683

0.0390%

$95.92K

+413.6%

Shefali Agarwal

Director

—

$36.81K (2)

−$36.81K

10,490

0.0088%

$21.55K

+1,200%

Karin Jooss

Director

—

$33.84K (1)

−$33.84K

9,848

0.0082%

$20.24K

—

Yuan Xu

Director

—

$24.33K (3) scheduled

−$24.33K

8,669

0.0072%

$17.81K

—

Brian T. Powl

Chief Commercial Officer

—

$18.77K (1)

−$18.77K

41,146

0.0343%

$84.55K

—

Robert Hershberg

Director

—

$15.29K (1)

−$15.29K

10,659

0.0089%

$21.90K

—

Kamal Adawi

Chief Financial Officer

—

$13.52K (1)

−$13.52K

93,418

0.0780%

$191.96K

—

Jerome Charles Bressi

See Remarks

—

$9.27K (1)

−$9.27K

335,203

0.2798%

$688.78K

+21.4%

Stewart Abbot

Chief Development Officer

—

—

—

64,917

0.0542%

$133.39K

+48.0%

Robert S Epstein

Director

—

—

—

36,331

0.0303%

$74.65K

—

Michael Stewart Lee

Director

—

—

—

11,331

0.0095%

$23.28K

—